Skip to main content
. 2019 Aug 14;105(3):721–729. doi: 10.3324/haematol.2019.225003

Figure 2.

Figure 2

Differences in outcome between patients with low and those with high 17-gene leukemic stem cell scores. (A) Disease-free survival (DFS) and (B) overall survival (OS) of younger adult patients (aged <60 years) according to the 17-gene leukemia stem cell (LSC) score. (C) DFS and (D) OS of older patients (aged ≥60 years) according to the 17-gene LSC score.